Can the bleeding potential of low molecular weight heparins be assessed and minimized in postsurgery prophylaxis?

Affiliations

Review

F Toulemonde. Semin Thromb Hemost. 1991 Oct.

. 1991 Oct;17(4):351-5.

doi: 10.1055/s-2007-1002634.

No abstract available

Similar articles

[Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
Hoffman R, Largiadèr F, Brütsch HP. Hoffman R, et al. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990:1179-84. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990. PMID: 1983509 Clinical Trial. German.
Clinical potential of low molecular weight heparins.
Messmore HL Jr. Messmore HL Jr. Semin Thromb Hemost. 1989 Oct;15(4):405-8. doi: 10.1055/s-2007-1002739. Semin Thromb Hemost. 1989. PMID: 2554501 Review. No abstract available.
Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
Kakkar VV. Kakkar VV. Semin Hematol. 1997 Oct;34(4 Suppl 4):9-19. Semin Hematol. 1997. PMID: 9399405 Review. No abstract available.
Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
Bergqvist D. Bergqvist D. Acta Chir Scand Suppl. 1988;543:87-9. Acta Chir Scand Suppl. 1988. PMID: 2847463 Review. No abstract available.
Low molecular weight heparins and bleeding.
Breddin HK. Breddin HK. Semin Thromb Hemost. 1989 Oct;15(4):401-4. doi: 10.1055/s-2007-1002738. Semin Thromb Hemost. 1989. PMID: 2479104 Review. No abstract available.

Prophylaxis of venous thromboembolism in brain tumor patients.
Hamilton MG, Hull RD, Pineo GF. Hamilton MG, et al. J Neurooncol. 1994;22(2):111-26. doi: 10.1007/BF01052887. J Neurooncol. 1994. PMID: 7745464 Review.